Documents confirm Canada's cozy relationship with pharma industry

The pandemic has killed an estimated 18 million people around the world, with many more dying in lower-income countries where vaccination rates remain low. Despite this, Canada continues to oppose an IP waiver at the WTO meaning that vaccines are only available in wealthier countries. We talk with Nikolas Barry-Shaw about how the Canadian government is working with the pharma industry to preserve patents on life-saving vaccines.